Get the Stockscreener App
77.79
0.12%
-0.09
After Hours:
77.79
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $77.79, with a volume of 6.26M.
It is down -0.12% in the last 24 hours and down -0.19% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$77.88
Open:
$77.64
24h Volume:
6.26M
Relative Volume:
0.85
Market Cap:
$98.75B
Revenue:
$393.94B
Net Income/Loss:
$428.00M
P/E Ratio:
203.32
EPS:
0.3826
Net Cash Flow:
$6.29B
1W Performance:
-3.76%
1M Performance:
-0.19%
6M Performance:
+16.38%
1Y Performance:
+71.80%
1-Day Range:
$77.36
$78.23
1-Week Range:
$77.13
$81.08
52-Week Range:
$43.56
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
77.79 | 98.86B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
UNH
Unitedhealth Group Inc
|
328.14 | 300.40B | 435.16B | 18.37B | 17.37B | 19.16 |
|
ELV
Elevance Health Inc
|
344.60 | 76.89B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
274.00 | 73.15B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
260.67 | 31.30B | 126.36B | 1.30B | 1.55B | 10.67 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Upgrade | UBS | Neutral → Buy |
| Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
3 Absurdly Cheap Stocks You Can Buy For Less than $100 Right Now - Finviz
2 Dividend Stocks to Buy for 2026 and Beyond - Finviz
CVS Health (NYSE:CVS) Issues FY 2025 Earnings Guidance - MarketBeat
Czech National Bank Boosts Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation (NYSE:CVS) Russell 1000 Integrated Care Role - Kalkine Media
Higher Guidance and Big Impairment Charges Might Change The Case For Investing In CVS Health (CVS) - Yahoo Finance
CVS: JP Morgan Raises Price Target and Maintains Overweight Rati - GuruFocus
Has the CVS Stock Surge in 2025 Already Priced In Its Cash Flow Potential? - simplywall.st
Health Insurers Now Get a Pulse: 3 Stocks to Jump in 2026 - Finviz
JPMorgan Chase & Co. Issues Positive Forecast for CVS Health (NYSE:CVS) Stock Price - MarketBeat
CVS/Aetna Medicare Advantage Plans Policy Holders Have - GlobeNewswire
Is Trending Stock CVS Health Corporation (CVS) a Buy Now? - Yahoo Finance
Texas Permanent School Fund Corp Decreases Stake in CVS Health Corporation $CVS - MarketBeat
Assenagon Asset Management S.A. Acquires 861,140 Shares of CVS Health Corporation $CVS - MarketBeat
9,900% Returns: Lessons From a Millionaire Janitor - The Motley Fool
CVS Health Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
CVS Health Stock (CVS) Opinions on 2025 Guidance Update - Quiver Quantitative
Staying healthy during the holidays with tips from CVS Health - CVS Health
Park National Corp OH Has $13.01 Million Holdings in CVS Health Corporation $CVS - MarketBeat
Shorepoint Capital Partners LLC Acquires New Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Stock Holdings Raised by Aaron Wealth Advisors LLC - MarketBeat
Press Release: Marsha Blackburn Questions CVS on Rising Health Care Costs and Fraud Allegations - Quiver Quantitative
CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents - TradingView — Track All Markets
CVS Health Shares Navigate Conflicting Market Cues - AD HOC NEWS
National Bank of Canada FI Sells 83,710 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health (CVS) Adjusts 2026 Revenue Outlook - GuruFocus
Stance Capital LLC Takes $1.99 Million Position in CVS Health Corporation $CVS - MarketBeat
Thompson Davis & CO. Inc. Makes New $1.14 Million Investment in CVS Health Corporation $CVS - MarketBeat
TD Cowen Increases CVS Health (NYSE:CVS) Price Target to $105.00 - MarketBeat
CVS Health Corporation $CVS Stock Holdings Raised by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
CVS Health Corp. stock outperforms competitors despite losses on the day - MarketWatch
Putting pharmacy education within reach - CVS Health
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term - Yahoo Finance
CVS: Bernstein Raises Price Target for CVS Health to $87 | CVS Stock News - GuruFocus
CVS Health Corporation $CVS Position Raised by Parkwood LLC - MarketBeat
Quantinno Capital Management LP Has $35.79 Million Stake in CVS Health Corporation $CVS - MarketBeat
Bernstein raises CVS Health stock price target to $87 on Aetna growth potential - Investing.com
CVS Health Corporation $CVS is Camber Capital Management LP's 4th Largest Position - MarketBeat
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
CVS Health (CVS): Reassessing Valuation After Raised 2025–2026 Guidance and New AI Consumer Platform - Yahoo Finance
CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak - Finviz
The Goldman Sachs Group Boosts CVS Health (NYSE:CVS) Price Target to $95.00 - MarketBeat
Jim Cramer on CVS: "This Stock Has Become the Best Performer in the Healthcare Sector" - Finviz
Jim Cramer on CVS: “This Stock Has Become the Best Performer in the Healthcare Sector” - Insider Monkey
Jim Cramer Recently Commented on These 10 Stocks - Insider Monkey
CVS Health (CVS) Receives Analyst Price Target Upgrade to $98 | - GuruFocus
CVS Health (CVS) Sees Analyst Rating Update from Piper Sandler | - GuruFocus
CVS Health Is Seeing Margin And App Momentum, Analyst Highlights - Benzinga
CVS Health Targets Steady Gains With A Revamped Game Plan - Finimize
CVS Health (CVS) Analysts Maintain Overweight, Raise Price Targe - GuruFocus
UBS Maintains Buy Rating, Raises Price Target for CVS to $97 | C - GuruFocus
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.39%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):